Cargando…
Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients
We previously found that leflunomide combined with low-dose prednisone rapidly improved the clinical symptoms of myasthenia gravis (MG), but we had not investigated the mechanism of this phenomenon. This study documents the effect of leflunomide combined with low-dose prednisone on pro-inflammatory...
Autores principales: | Huang, Xin, Ran, Hao, Li, Yingkai, Ma, Qian, Ou, Changyi, Qiu, Li, Feng, Huiyu, Liu, Weibin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508276/ https://www.ncbi.nlm.nih.gov/pubmed/36164461 http://dx.doi.org/10.3389/fneur.2022.961628 |
Ejemplares similares
-
Corrigendum: Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients
por: Huang, Xin, et al.
Publicado: (2023) -
Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China
por: Huang, Xin, et al.
Publicado: (2018) -
Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021) -
Application of lymphoplasmapheresis in the treatment of severe myasthenia gravis
por: Duan, Weiwei, et al.
Publicado: (2022) -
Editorial: Phenotypes of myasthenia gravis
por: Li, Hai-Feng, et al.
Publicado: (2022)